Ebola cases in DR Congo more than double, WHO warns
DR Congo's Bundibugyo Ebola outbreak has topped 11,000 cases and 5,400 deaths, WHO says, with children hit hardest and cases reaching Kenya and Nigeria.

The Ebola outbreak in the Democratic Republic of the Congo has more than doubled in three months, with more than 11,000 cases and 5,400 deaths reported in 67 health zones across eight provinces, the head of the World Health Organization said on Tuesday. Children are bearing the heaviest toll: they account for more than a quarter of confirmed cases and a third of deaths, and seven in ten children under five with confirmed Ebola have died.
"The risk beyond the DRC's borders is not theoretical," Director-General Tedros Adhanom Ghebreyesus told the third meeting of WHO's Emergency Committee on the Bundibugyo virus epidemic, UN News reported. Kenya has reported nine cases linked to an imported case, including two deaths, and Nigeria has reported one imported case.
There has been progress. Rapid transmission has been halted in most early epicentres, laboratories able to test for the virus have risen from two to more than two dozen, and two candidate vaccines developed for the Bundibugyo strain will join an ongoing trial in the coming weeks. But Dr Tedros warned that progress in some places is not control of the whole outbreak: 400 to 500 new cases are still reported each week, and two-thirds of confirmed deaths happen outside treatment centres, a sign infections are caught too late. He also criticised blanket travel restrictions, which he said hinder the response and discourage countries from reporting quickly.
The economic stakes were spelt out in a second announcement on Tuesday. A joint report by the UN Environment Programme and WHO found that exposure to endocrine-disrupting chemicals — which interfere with the body's hormones — can begin before birth, with lasting effects on brain development, growth and reproductive health. More than 350,000 chemicals and mixtures are registered for production and use globally, yet only a small fraction have been evaluated for endocrine-disrupting properties. The study estimates the global cost of diseases associated with such exposure could reach one per cent or more of global GDP. The report was launched at the first International Conference of the Global Framework on Chemicals, which runs in Geneva until 20 November.
Separately, UN human rights chief Volker Türk raised concern about a proposal to transfer people from five European Union countries to Rwanda — people who, he said, have "no genuine connection" to a country with "its own set of human rights challenges". His office has not seen the text of the proposal. He argued against "externalising human rights obligations" and urged governments instead to tackle the drivers of migration, including inequality, conflict and an economic system that disadvantages many countries in the Global South — while expanding regular migration pathways as northern societies age and face labour shortages.
The next test comes in the coming weeks, when the two Bundibugyo vaccine candidates enter the Congo trial — and when the chemicals conference in Geneva closes on 20 November with governments expected to set out their next steps.
Sources
This article is based on reporting from:


